These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24239030)

  • 1. Interim versus standard methadone treatment: a benefit-cost analysis.
    Schwartz RP; Alexandre PK; Kelly SM; O'Grady KE; Gryczynski J; Jaffe JH
    J Subst Abuse Treat; 2014 Mar; 46(3):306-14. PubMed ID: 24239030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail.
    Zarkin GA; Orme S; Dunlap LJ; Kelly SM; Mitchell SG; O'Grady KE; Schwartz RP
    Drug Alcohol Depend; 2020 Dec; 217():108292. PubMed ID: 32992151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.
    Schwartz RP; Kelly SM; Mitchell SG; Dunlap L; Zarkin GA; Sharma A; O'Grady KE; Jaffe JH
    Contemp Clin Trials; 2016 Jul; 49():21-8. PubMed ID: 27282117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone treatment of arrestees: A randomized clinical trial.
    Schwartz RP; Kelly SM; Mitchell SG; O'Grady KE; Sharma A; Jaffe JH
    Drug Alcohol Depend; 2020 Jan; 206():107680. PubMed ID: 31753737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
    Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
    Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are supplementary services provided during methadone maintenance really cost-effective?
    Kraft MK; Rothbard AB; Hadley TR; McLellan AT; Asch DA
    Am J Psychiatry; 1997 Sep; 154(9):1214-9. PubMed ID: 9286179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine for opiate addiction: potential economic impact.
    Rosenheck R; Kosten T
    Drug Alcohol Depend; 2001 Aug; 63(3):253-62. PubMed ID: 11418229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim methadone treatment compared to standard methadone treatment: 4-month findings.
    Schwartz RP; Kelly SM; O'Grady KE; Gandhi D; Jaffe JH
    J Subst Abuse Treat; 2011 Jul; 41(1):21-9. PubMed ID: 21353445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.
    Nosyk B; Guh DP; Bansback NJ; Oviedo-Joekes E; Brissette S; Marsh DC; Meikleham E; Schechter MT; Anis AH
    CMAJ; 2012 Apr; 184(6):E317-28. PubMed ID: 22410375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic costs of jail-based methadone maintenance treatment.
    Horn BP; Li X; Mamun S; McCrady B; French MT
    Am J Drug Alcohol Abuse; 2018; 44(6):611-618. PubMed ID: 30024783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.
    Schwartz RP; Jaffe JH; Highfield DA; Callaman JM; O'Grady KE
    Drug Alcohol Depend; 2007 Jan; 86(1):30-6. PubMed ID: 16793221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients.
    Jofre-Bonet M; Sindelar JL; Petrakis IL; Nich C; Frankforter T; Rounsaville BJ; Carroll KM
    J Subst Abuse Treat; 2004 Apr; 26(3):225-32. PubMed ID: 15063917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of methadone treatment initiated in jail on subsequent arrest.
    Kelly SM; Schwartz RP; O'Grady KE; Mitchell SG; Duren T; Sharma A; Jaffe JH
    J Subst Abuse Treat; 2020 Jun; 113():108006. PubMed ID: 32359668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of methadone maintenance treatment in Lithuania.
    Vanagas G; Padaiga Z; Bagdonas E
    Medicina (Kaunas); 2010; 46(4):286-92. PubMed ID: 20571298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial.
    Kidorf M; Brooner RK; Leoutsakos JM; Peirce J
    Drug Alcohol Depend; 2018 Jun; 187():343-350. PubMed ID: 29709732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methadone maintenance programs with supplementary services: a cost-effectiveness study].
    Puigdollers E; Cots F; Brugal MT; Torralba L; Domingo-Salvany A
    Gac Sanit; 2003; 17(2):123-30. PubMed ID: 12729539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.